Neos Therapeutics Completes $20.6 Million Financing to Further Advance its Late-Stage ADHD Product Pipeline

Neos Therapeutics, Inc. , a specialty pharmaceutical company with a late-stage pipeline of innovative extended-release products for Attention-Deficit Hyperactivity Disorder , today announced that it has completed an oversubscribed round of financing, raising a total of $20.6 million.

from Content Keyword RSS http://ift.tt/1vyoi7d http://ift.tt/eA8V8J

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s